Passage Bio, Inc. (PASG) Misses Q3 EPS by 8c
Passage Bio, Inc. (NASDAQ: PASG) reported Q3 EPS of ($0.31), $0.08 worse than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.
Passage Bio, Inc. (NASDAQ: PASG) reported Q3 EPS of ($0.31), $0.08 worse than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.